
Amarin Corporation plc AMRN
$ 14.33
-0.69%
Quarterly report 2026-Q1
added 04-29-2026
Amarin Corporation plc P/S Ratio 2011-2026 | AMRN
Annual P/S Ratio Amarin Corporation plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.2 | 25.1 | 1.43 | 2.22 | 2.29 | 3.04 | 15.2 | 22 | 5.72 | 4.67 | 3.01 | 3.27 | 11 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.2 | 1.43 | 9.7 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 7.15 | 1.64 % | $ 196 M | ||
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.69 | 4.66 % | $ 198 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 92.82 | 0.74 % | $ 22.4 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Compugen Ltd.
CGEN
|
2.7 | $ 2.72 | -2.86 % | $ 254 M | ||
|
Abcam plc
ABCM
|
13.7 | - | - | $ 4.9 B | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.13 | -0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
6.99 | $ 31.47 | -3.44 % | $ 847 M | ||
|
Affimed N.V.
AFMD
|
13.1 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
181 | $ 21.98 | 1.81 % | $ 285 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
21.3 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
30.3 | - | - | $ 344 M | ||
|
IMV
IMV
|
48.2 | - | - | $ 13.1 M | ||
|
Grifols, S.A.
GRFS
|
0.627 | $ 8.03 | 0.56 % | $ 5.46 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
1.28 | $ 0.87 | 1.11 % | $ 145 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
2.54 | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
1.9 | $ 14.63 | -1.68 % | $ 210 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
InflaRx N.V.
IFRX
|
2.16 K | $ 2.76 | 5.75 % | $ 186 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
41.6 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.49 | 2.65 % | $ 5.75 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.5 | - | -0.23 % | $ 916 M |